Published in Blood Weekly, August 19th, 1996
"While clinical significance of these findings remains to be established, it has not escaped our notice that the subcutaneous administration of IL-2 and antiretroviral therapy has the potential to maintain...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.